Compass Minerals Q3 Revenue Beats, Full-Year Guidance Raised on Plant Nutrition Strength
CMP sits 83% above its 52-week low of $16.395.
Summary
Compass Minerals reported fiscal Q3 2026 revenue of $215.3M, beating consensus, and raised full-year Adjusted EBITDA guidance to a midpoint of $230M, driven by a 32% jump in Plant Nutrition segment EBITDA. Net leverage improved to 2.8x, and S&P upgraded the credit rating to B+.
Key Events · Earnings and Guidance · CMP
-
Q3 Revenue Beat
Revenue of $215.3M exceeded the $206.67M consensus, while net loss narrowed to $5.7M from $17.0M a year ago.
-
Full-Year Guidance Raised
Total company Adjusted EBITDA guidance raised to $218M-$242M (midpoint $230M), up from prior range, driven by Plant Nutrition strength.
-
Plant Nutrition Turnaround
Plant Nutrition Adjusted EBITDA surged 32% YoY to $15.0M; full-year segment EBITDA guidance raised to $49M-$57M from $43M-$47M.
-
Salt Segment Mixed
Salt revenue up 5% on higher pricing, but Adjusted EBITDA fell 15% YoY to $38.9M due to elevated production costs; full-year Salt EBITDA guidance narrowed to $225M-$236M.
Analysis · CMP · Energy & Transportation
Compass Minerals delivered a Q3 revenue beat and raised its full-year Adjusted EBITDA guidance, driven by a sharp turnaround in Plant Nutrition. The segment's Adjusted EBITDA jumped 32% year-over-year on better pricing and lower costs, prompting management to lift its full-year Plant Nutrition EBITDA forecast by up to 21%. Salt results were mixed — highway pricing improved, but production costs remain elevated, leading to a slight trim in Salt segment guidance. The balance sheet continues to strengthen: net leverage fell to 2.8x from 4.3x a year ago, and S&P upgraded the corporate credit rating to B+. The improved outlook and deleveraging signal that the operational turnaround is gaining traction, though cost pressures in Salt mining operations remain a watchpoint.
At the time of this filing, CMP was trading at $30.03 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $16.40 to $34.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.